Skip to main content
  • Letter to the editor
  • Open access
  • Published:

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination

Abstract

This correspondence discussed on published article on “thromboses of major arteries and ChAdOx1 nCov-19 vaccination”.

Dear Editor, we would like to share ideas on the publication “Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination [1].” Zarrouk and Finsterer concluded that “Both were successfully treated with intravenous immunoglobulins and non-heparin anticoagulant agents …. in case 1 and four months in case 2. [1].” Thrombosis might occur in post COVID-19 vaccination. In the present case, the pathogenesis is still unclear. A possible mechanism in the present case is hyperviscosity following vaccination [2]. This is due to rapid change of blood viscosity due to immunogenicity process of COVID-19 vaccine [2]. The successful of treatment by non-heparin anticoagulant agents can support that the main pathological problem is not on coagulation component and platelet but plasma viscosity. Additionally, when there is a decline in stimulation, a decreased blood viscosity occurs and it is concordant with the observation that the patients improved within 6 weeks.

Availability of data and materials

Not applicable.

Abbreviations

COVID-19:

Coronavirus disease 2019

References

  1. Goereci, Y., Kleineberg, N. N., Madlener, M., Neuschmelting, H., Fink, G. R., Warnke, C., & Stetefeld, H. (2021). Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination. Neurological Research and Practice, 3(1), 52.

    Article  Google Scholar 

  2. Joob, B., & Wiwanitkit, V. (2021). Expected viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19. Clinical and Applied Thrombosis/Hemostasis, 27, 10760296211020832.

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

RM: 50% ideas, drafting, writing, final approval for submission. VW: 50% ideas, supervising, final approval for submission. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Rujittika Mungmunpuntipantip.

Ethics declarations

Ethical approval and consent to participate

Not applicable.

Consent for publication

Consent.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mungmunpuntipantip, R., Wiwanitkit, V. Thromboses of major arteries and ChAdOx1 nCov-19 vaccination. Neurol. Res. Pract. 3, 61 (2021). https://doi.org/10.1186/s42466-021-00160-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s42466-021-00160-x

Keywords